{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:16:33Z","timestamp":1773296193289,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.01.064","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T06:09:07Z","timestamp":1455084547000},"page":"1452-1458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation"],"prefix":"10.1016","volume":"34","author":[{"given":"Michael J.","family":"Springer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Finger-Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan P.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley V.","family":"DiMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Kobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobbi","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Talton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald R.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.064_bib0185","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3201\/eid0506.990624","article-title":"Food-related illness and death in the United States","volume":"5","author":"Hedberg","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0190","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(94)92146-6","article-title":"Small round structured viruses: airborne transmission and hospital control","volume":"343","author":"Caul","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0195","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","article-title":"Norovirus disease in the United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0200","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3201\/eid0506.990625","article-title":"Food-related illness and death in the United States reply to Dr. Hedberg","volume":"5","author":"Mead","year":"1999","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.vaccine.2016.01.064_bib0205","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3201\/eid1408.071114","article-title":"Systematic literature review of role of noroviruses in sporadic gastroenteritis","volume":"14","author":"Patel","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1099\/vir.0.81532-0","article-title":"Genetic and antigenic diversity among noroviruses","volume":"87","author":"Hansman","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virusres.2010.06.018","article-title":"Complete genome sequence and phylogenetic analysis of a recombinant Korean norovirus, CBNU1, recovered from a 2006 outbreak","volume":"152","author":"Yun","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/499315","article-title":"Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000\u20132004","volume":"193","author":"Blanton","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/341085","article-title":"Epidemiologic and molecular trends of \u201cNorwalk-like viruses\u201d associated with outbreaks of gastroenteritis in the United States","volume":"186","author":"Fankhauser","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.01622-09","article-title":"Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006","volume":"48","author":"Zheng","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2008.00680.x","article-title":"Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations","volume":"225","author":"Donaldson","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0240","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2006.03.080","article-title":"Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains","volume":"24","author":"LoBue","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.vaccine.2014.09.073","article-title":"Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine","volume":"33","author":"Sundararajan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/erv.09.163","article-title":"Norwalk virus-like particles as vaccines","volume":"9","author":"Herbst-Kralovetz","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0255","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1521-6616(03)00120-7","article-title":"Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers","volume":"108","author":"Tacket","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0265","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymeth.2006.05.020","article-title":"Virus-like particles production in green plants","volume":"40","author":"Santi","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0275","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1128\/JVI.71.10.8066-8072.1997","article-title":"Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells","volume":"71","author":"White","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0280","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0285","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0290","series-title":"In-situ gel formation of pectin. In: USPTO, editor.","author":"Ni YaY","year":"2004"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0295","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2008.01.053","article-title":"An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles","volume":"26","author":"Santi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0300","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal antibody-based antigenic mapping of norovirus GII. 4-2002","volume":"86","author":"Lindesmith","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0305","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/JVI.03106-12","article-title":"Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes","volume":"87","author":"Lindesmith","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0310","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","article-title":"Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0315","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/gast.2002.33661","article-title":"Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals","volume":"122","author":"Marionneau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0320","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/infdis\/jit620","article-title":"Determination of the 50% human infectious dose for Norwalk virus","volume":"209","author":"Atmar","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0325","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiu497","article-title":"Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults","volume":"211","author":"Bernstein","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/CVI.00516-14","article-title":"Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity","volume":"22","author":"Czako","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0335","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0340","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1128\/JVI.79.12.7402-7409.2005","article-title":"Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid","volume":"79","author":"Parker","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0345","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults","volume":"210","author":"Treanor","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0350","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00196-15","article-title":"Serological correlates of protection against a GII.4 norovirus","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0355","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.1014577107","article-title":"Chimpanzees as an animal model for human norovirus infection and vaccine development","volume":"108","author":"Bok","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.01.064_bib0360","series-title":"Vaccines","author":"Plotkin","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T05:49:41Z","timestamp":1600148981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001547"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}